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A woman living in the United States has approximately a one in eight chance of developing 
breast cancer within her lifetime. The main cause of death associated with breast cancer is from 
metastatic spread of the disease, with the most frequent sites of spread being the bone, brain, and 
lungs. The urinary bladder is an uncommon site of metastasis, rarely reported on in the literature. 
In this report, we present a case of recurrent metastatic breast cancer found in the urinary bladder 
with no other sites of metastatic spread. A thorough history should be obtained in all patients, 
and in patients with a previous history of cancer, reoccurrence and distant spread should be kept 













The patient is a 61-year-old female with a history of locally advanced ER/PR+, HER-2 negative 
breast cancer diagnosed in September 2002. At the time of her diagnosis, she underwent 
neoadjuvant chemotherapy, followed by a mastectomy with sentinel lymph node biopsy where 
five of eight lymph nodes were found to be positive. She was treated with adjuvant Taxotere for 
four cycles, after which she received radiation to her chest wall. She completed her radiation 
therapy in August 2003 and received tamoxifen until 2009. At that time, she was switched to 
Femara and went on to complete more than five years of therapy. During her therapy, she was 
under regular surveillance, which included mammograms and clinic visits that showed no 
findings of recurrent disease.  
 
Of note, this patient had a past medical history of asthma, diabetes type II, hyperlipidemia, 
hypertension, osteoarthritis, and hypothyroidism. She reported no tobacco or drug use and only 
mild alcohol consumption. Both parents are alive, and there is no known family history of breast 
cancer.  
 
In April 2019, she presented with lower abdominal pain and hematuria for which she underwent 
a cystoscopy. The examination showed a single large sessile neoplasm in the upper dome region 
of the bladder. Transurethral resection of the bladder tumor was completed with pathology 
findings of ER/PR + HER-2 negative breast carcinoma. A systemic workup, which included CT 
scans of the chest, abdomen, and pelvis, and a bone scan were completed. Findings included a 
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thyroid nodule, which was negative for malignancy on fine-needle aspiration, and a palpable 
lymph node in her right inguinal region, which was biopsied and also negative.  
 
The patient was started on daily letrozole and cycles of palbociclib. She continued on calcium 
and vitamin D supplements. She tolerated this regimen well. The most recent mammogram of the 




Secondary tumors found in the bladder, such as metastasis, are rare and account for only two 
percent of bladder tumors.1 Most of these are from direct invasion from adjacent structures in the 
pelvis.2 Due to the rarity of metastasis from the breast to the bladder, screening for bladder 
metastasis is typically triggered only by symptoms such as lower abdominal pain or hematuria, 
which is how our patient presented. Even more rare are findings of metastasis incidentally 
without symptoms.3  
 
Differentiating between primary bladder neoplasm and metastasis requires biopsy and 
pathological examination. One would expect homogenous expression of ER/PR receptors 
between the primary neoplasm in the breast and the metastasis. However, heterogenic expression 
between the primary breast tumor and the metastatic lesion is not uncommon, with some studies 
showing 20 to 40 percent of patients demonstrating discordance.4 This makes for an important 
distinction between primary versus metastatic neoplasms of the bladder and possible treatment 
modalities.  
 
Another point to consider is how breast cancer can metastasize to the bladder with no local 
involvement. Previously, it was believed that metastasis to the bladder occurred through the 
extension of retroperitoneal masses. However, another proposed mechanism occurs through 
venous emboli.5 The theory of metastatic emboli from a primary source could account for both 
solitary bladder involvement and the presence of metastasis in the absence of gross disease 
reoccurrence.  
 
This leads us to consider if there is enough evidence to promote routine screening for bladder 
metastasis in breast cancer patients. As patients with breast cancer live longer, we may need to 
be more vigilant to uncover atypical presentations of metastasis, especially those that tend to 
present late. At this time, the evidence of metastasis is still less than five percent, with many of 




Currently, there is insufficient evidence to support routine screening for bladder metastasis 
without symptoms. However, the evidence is significant enough to allow for a higher index of 
suspicion in patients presenting with urinary symptoms and a history of breast cancer to 
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